Abbvie’s Rinvoq achieves primary endpoint in late-stage Crohn’s Disease trial
December 06 2021 - 9:06AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Mar 2024 to Apr 2024
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Apr 2023 to Apr 2024